Somatic FBW7 mutation in squamous cell carcinoma cells is associated with stabilized Mcl-1 and high Bim levels, resulting in a poor response to standard chemotherapy, but a robust response to HDAC inhibitors and enhanced synergy with the combination vorinostat/ABT-737 [579]. The gene discussed is HDAC9; the disease is squamous cell carcinoma.